1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Revance Therapeutics Inc (RVNC)
  7. Quote


Revance Therapeutics Stock Price

0.04 (0.29%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 5,752,153
Bid Price 13.75
Ask Price 13.87
News -
Day High 14.06


52 Week Range


Day Low 13.25
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Revance Therapeutics Inc RVNC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 0.29% 13.85 19:50:34
Open Price Low Price High Price Close Price Prev Close
14.05 13.25 14.06 13.85 13.81
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
39,386 5,752,153 $ 13.81 $ 79,412,688 - 13.01 - 33.83
Last Trade Time Type Quantity Stock Price Currency
19:53:34 39 $ 13.87 USD


Draw Mode:

Revance Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 994.84M 71.83M 69.05M $ 15.33M $ - -4.85 -4.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -71.37k 2.50%

more financials information »

Revance Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RVNC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week27.3027.4413.0116.825,474,104-13.45-49.27%
1 Month27.7730.0013.0118.721,662,191-13.92-50.13%
3 Months29.5830.5713.0121.54821,879-15.73-53.18%
6 Months27.0533.8313.0124.52600,939-13.20-48.8%
1 Year25.7733.8313.0125.51540,080-11.92-46.26%
3 Years24.1634.629.8821.35537,481-10.31-42.67%
5 Years14.7037.459.8822.87428,387-0.85-5.78%

Revance Therapeutics Description

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are Product and the Service Segment. The Products segment generates maximum revenue which is engaged in research and development of aesthetic and therapeutic products.

Your Recent History
Revance Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.